Company Filing History:
1 out of 38 
1 out of 4 
1 out of 7 Years Active: 1986-1990
Title: Morris Stolar: Innovator in Cardiac Arrhythmia Treatment
Introduction
Morris Stolar is a notable inventor based in Tel Aviv, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cardiac arrhythmia. With a total of 3 patents, Stolar's work has the potential to impact many lives.
Latest Patents
Stolar's latest patents include innovative compounds known as 2-alkyl-3-benzoylbenzofurans, which are useful for treating cardiac arrhythmia. One of his patents discloses new 2-alkyl-3-(4-hydroxy-3,5-di-tert-butylbenzoyl)benzofurans, along with pharmaceutical compositions containing these benzofurans and methods for treating cardiac arrhythmia. Another patent focuses on 2-alkyl-3-[4-(omega-N,N-dialkylaminoacylamino)-3,5-dialkylbenzoyl]benzofurans, also aimed at treating cardiac arrhythmia, along with related pharmaceutical compositions and treatment methods.
Career Highlights
Throughout his career, Stolar has worked with prominent companies in the pharmaceutical industry, including Taro Pharmaceutical Industries Limited and Taro Pharmaceuticals Inc. His experience in these organizations has contributed to his expertise in developing innovative treatments.
Collaborations
Stolar has collaborated with notable professionals in his field, including Barrie Levitt and Ron Breiman. These collaborations have likely enriched his research and development efforts.
Conclusion
Morris Stolar's contributions to the treatment of cardiac arrhythmia through his innovative patents highlight his role as a significant inventor in the pharmaceutical industry. His work continues to pave the way for advancements in medical treatments.